Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model. [PDF]
Clin Transl SciShi A, Agarwal P, Liu ZX, Beringer PM.
europepmc +1 more source
Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries. [PDF]
Pediatr PulmonolKerem E.
europepmc +1 more source
Target-Guided Design and Synthesis of Aryl-Functionalized Promysalin Analogs. [PDF]
ChembiochemGolden MM, Brzezinski CU, Wuest WM.
europepmc +1 more source
Molecular interactions between piperine and peroxisome proliferator-activated receptor gamma ligand-binding domain revealed using co-crystallization studies. [PDF]
Acta Crystallogr F Struct Biol CommunEgawa D, Ishida H, Katakawa K.
europepmc +1 more source
Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]
J Bras PneumolSilva SC +4 more
europepmc +1 more source
Aldehyde Dehydrogenase-2 Alleviates Septic Myocardial Injury by Inhibiting Caspase-11-Mediated Noncanonical Pyroptosis. [PDF]
Cardiovasc TherLiang H +7 more
europepmc +1 more source
Cepharanthine inhibits the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma via HMGA2/FOXL2 axis. [PDF]
BMC Pharmacol ToxicolHuang Y, Huang J, Zhang X.
europepmc +1 more source
Piperine and Tabersonine, but Not Lupinine, Inhibit <i>S. proteamaculans</i> Invasion of M-HeLa Cells. [PDF]
Int J Mol SciBozhokina E, Berson Y, Tsaplina O.
europepmc +1 more source
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis. [PDF]
Respir ResGramegna A +7 more
europepmc +1 more source
The Activation of Aldehyde Dehydrogenase 2 (ALDH2) by Alda-1 and Flurbiprofen as a Common Mechanism to Reduce Alcohol Intake in Rats. [PDF]
Int J Mol SciTorres JM +6 more
europepmc +1 more source